Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel oral suspension pharmacokinetics and safety study in infants and young children with epilepsy
2013-005391-17Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2016
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perampanel in epilepsy, sponsored by Eisai Co., Ltd. Primary endpoint: Pharmacokinetics of perampanel. Started Jul 2016; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2013-005391-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005391-17.